Search Results - "De Felippis, Michael R"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies by Huang, Lihua, Wang, Ning, Mitchell, Charles E, Brownlee, Tammy, Maple, Steven R, De Felippis, Michael R

    Published in Analytical chemistry (Washington) (16-05-2017)
    “…Residual host cell proteins (HCPs) in biopharmaceuticals derived from recombinant DNA technology can present potential safety risks to patients or compromise…”
    Get full text
    Journal Article
  2. 2

    Endotoxin recovery using limulus amebocyte lysate (LAL) assay by Bolden, Jay S., Warburton, Rob E., Phelan, Robert, Murphy, Marie, Smith, Kelly R., De Felippis, Michael R., Chen, Dayue

    Published in Biologicals (01-09-2016)
    “…A phenomenon initially reported by Chen and Vinther in 2013 [1], and now commonly referred to as low endotoxin recovery (LER), has prompted the Food and Drug…”
    Get full text
    Journal Article
  3. 3

    Identification of Racemization Sites Using Deuterium Labeling and Tandem Mass Spectrometry by Huang, Lihua, Lu, Xiaojun, Gough, P. Clayton, De Felippis, Michael R

    Published in Analytical chemistry (Washington) (01-08-2010)
    “…Racemization of amino acids is a common chemical degradation pathway observed in biopharmaceuticals and is particularly prevalent in synthetic peptides. The…”
    Get full text
    Journal Article
  4. 4

    Subcutaneous Injection Site Pain of Formulation Matrices by Shi, Galen H., Pisupati, Karthik, Parker, Jonathan G., Corvari, Vincent J., Payne, Christopher D., Xu, Wen, Collins, David S., De Felippis, Michael R.

    Published in Pharmaceutical research (01-05-2021)
    “…Purpose The objective of this work was to systematically evaluate the effects of formulation composition on subcutaneous injection site pain (ISP) using…”
    Get full text
    Journal Article
  5. 5

    Method for Characterization of PEGylated Bioproducts in Biological Matrixes by Liu, Qingyuan, De Felippis, Michael R., Huang, Lihua

    Published in Analytical chemistry (Washington) (15-10-2013)
    “…PEGylation of peptides and proteins has been widely used to enhance stability and reduce immunogenicity of biotherapeutics. Characterizing the degradation of…”
    Get full text
    Journal Article
  6. 6

    How long should insulin be used once a vial is started? by GRAJOWER, Martin M, FRASER, Charles G, HOLCOMBE, John H, DAUGHERTY, Marci L, HARRIS, William C, DE FELIPPIS, Michael R, SANTIAGO, Olga M, CLARK, Nathaniel G

    Published in Diabetes care (01-09-2003)
    “…Grajower et al examine the potency of opened and refrigerated human insulin vials. The stability of human insulin vials is dependent upon a number of factors…”
    Get full text
    Journal Article
  7. 7

    Non-native intermediate conformational states of human growth hormone in the presence of organic solvents by Sukumar, Muppalla, Storms, Sacha M, De Felippis, Michael R

    Published in Pharmaceutical research (01-05-2005)
    “…Manufacturing processes expose protein pharmaceuticals to organic solvents that may perturb the native folded state, increasing the potential for irreversible…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10